Almost one in four final salary pension schemes close in 2012Call for Budget clarity on retirement income limit of €60,000Tue Oct 01 2013 - 11:15
Government ‘likely to broaden tax base’ rather than increasing ratesIrish Tax Institute calls for incentives for investors and entrepreneurs and PRSI reformWed Sept 25 2013 - 21:08
Alkermes’s key strength is potent pharma pipelineAn inspired approach to clinical trial data is fuelling the firm’s assault on central nervous system ailmentsMon Sept 23 2013 - 01:00
Alkermes hosts gathering of US investorsGroup of investment firms looking at investment opportunities in EuropeSun Sept 15 2013 - 23:05
Broker disqualified from managing regulated businessTallaght insurance firm took €121,250 from client accounts over 27 monthsTue Sept 10 2013 - 19:50
Charities found wanting in resistance to regulationBusiness Opinion: reform of Irish charities legislation is badly neededMon Aug 19 2013 - 01:00
Reprehensible budget kite-flying on old-age pension designed to target the most vulnerableOpinion: failure to hold the line against cutting pension payments would add acutely to Labour’s electoral worriesMon Aug 12 2013 - 01:00
Pfizer to invest $130m in two Irish plantsUS company will inject $100m into Grange Castle biologics unit and $30m at RingaskiddyThu Jul 11 2013 - 09:14
Amarin announces plan to sell another 21.7 million sharesProceeds will fund ongoing rollout of Vascepa fish oil drug in the USTue Jul 09 2013 - 20:01
Urgent reform of pension wind-up priority order soughtEmployers, unions and pensions industry unite to call for action to protect workers’ benefitsMon Jul 08 2013 - 22:41
Shameful silence over broken pension promisesOpinion: when an Irish company reneges on the promise of certain retirement income, there is no outrage, no reaction, only silenceMon Jul 08 2013 - 01:00
American chamber hits out at ‘unfair’ spotlight on multinationals’ tax treatmentSurvey shows 1,400 open positions at 100 US firms operating in IrelandFri Jul 05 2013 - 01:00
Ibec chief accuses Government of ‘malign neglect’ on pensionsMcCoy questions whether defined benefit pension schemes now too dangerousWed Jun 26 2013 - 20:40
Ibec condemns Government for inaction on pensionsBusiness group says many schemes will be forced to closeWed Jun 26 2013 - 01:00
Spurned suitor still chasing elusive Elan takeover dealThe chief executive of Royalty Pharma is still keen to talk to Ireland’s largest indigenous pharma group about making a deal workFri Jun 21 2013 - 01:00
‘Little blue pill’ heads over the cliff in another headache for big pharmaIt’s a feeling Pfizer knows only too well, having seen sales of Lipitor plummet 60 per centFri Jun 21 2013 - 01:00
Words not figures proved the undoing of Royalty’s hostile Elan bidCompany has only itself to blameWed Jun 19 2013 - 01:09
Burton declines to rule out further levy on pensionsPensions Board chief says it is clear a number of schemes will close downMon Jun 17 2013 - 21:48
Elan loses shareholder support but Royalty bid may also perishOutcome of special meeting in Dublin leaves sides effectively in stalemateMon Jun 17 2013 - 19:57
Elan paid $250,000 to former director over SEC referralCompany referred publicly to Jack Schuler as a ‘disgruntled director’Mon Jun 17 2013 - 01:00
Elan shareholders mull the unravelling of a businessHow the Irish biotech firm got to this point and how the EGM may play outSun Jun 16 2013 - 16:02
Elan puts itself on market as prospects for restructuring plan fadeReview of proxies suggests stalemate after four-month battle for control of companyFri Jun 14 2013 - 21:01
Failure of Royalty Pharma bid likely to hit Elan share price, say analystsFate of $6.7bn offer will be decided by shareholders at extraordinary general meeting on MondayThu Jun 13 2013 - 01:00
Elan bid defence under attack from former directorElan dismisses claims by Jack Schuler whom it calls ‘disgruntled’ as Royalty challenges Takeover Panel rulingWed Jun 12 2013 - 08:46
Royalty Pharma challenges ruling that it must withdraw Elan bidDeadline looms for vote of proxies in bitter battleWed Jun 12 2013 - 01:00
Irish-based Royalty Pharma are already a major player in fieldFounded in 1996, it built a major business by procuring the rights to royalties of some of the major drugs in the market, including Humira, Januvia, Lyrica and RemicadeTue Jun 11 2013 - 01:27
Elan drops NY lawsuit and rejects latest Royalty Pharma bidBidder calls on shareholders to reject all defensive acquisitions at upcoming EGMTue Jun 11 2013 - 01:02
Elan formally rejects enhanced Royalty Pharma offerElan continues to insist the offer “substantially undervalues” the value of TysabriTue Jun 04 2013 - 01:00
Trino Therapeutics secures $12m to develop new class of drugs for inflammatory diseasesTrinity College spin-out will initially target mild to moderate ulcerative colitisTue May 28 2013 - 10:30
Q&A Dominic CoyleIs Revenue allowed charge fee for credit card payment of property tax?Tue May 28 2013 - 01:00
Finding the right formula for growthMSD Ireland’s new boss sees a central role for operations here despite ongoing rationalisationFri May 24 2013 - 01:01
Alkermes moves into profit as Elan deliversCompany brings fiscal year in line with calendarThu May 23 2013 - 22:06
